Ionis Pharmaceuticals Statistics
Total Valuation
IONS has a market cap or net worth of $9.41 billion. The enterprise value is $9.50 billion.
| Market Cap | 9.41B |
| Enterprise Value | 9.50B |
Important Dates
The last earnings date was Wednesday, July 29, 2026, before market open.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IONS has 166.18 million shares outstanding. The number of shares has increased by 4.49% in one year.
| Current Share Class | 166.18M |
| Shares Outstanding | 166.18M |
| Shares Change (YoY) | +4.49% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 0.76% |
| Owned by Institutions (%) | 104.16% |
| Float | 162.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.54 |
| Forward PS | 9.69 |
| PB Ratio | 20.88 |
| P/TBV Ratio | 20.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.89, with a Debt / Equity ratio of 4.98.
| Current Ratio | 7.89 |
| Quick Ratio | 6.85 |
| Debt / Equity | 4.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.14 |
Financial Efficiency
Return on equity (ROE) is -105.50% and return on invested capital (ROIC) is -72.03%.
| Return on Equity (ROE) | -105.50% |
| Return on Assets (ROA) | -12.42% |
| Return on Invested Capital (ROIC) | -72.03% |
| Return on Capital Employed (ROCE) | -3.82% |
| Weighted Average Cost of Capital (WACC) | 5.83% |
| Revenue Per Employee | $590,603 |
| Profits Per Employee | -$381,874 |
| Employee Count | 1,480 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 31.52 |
Taxes
In the past 12 months, IONS has paid $3.17 million in taxes.
| Income Tax | 3.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.59% in the last 52 weeks. The beta is 0.40, so IONS's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +38.59% |
| 50-Day Moving Average | 66.16 |
| 200-Day Moving Average | 74.49 |
| Relative Strength Index (RSI) | 43.81 |
| Average Volume (20 Days) | 2,929,049 |
Short Selling Information
The latest short interest is 20.04 million, so 12.06% of the outstanding shares have been sold short.
| Short Interest | 20.04M |
| Short Previous Month | 17.43M |
| Short % of Shares Out | 12.06% |
| Short % of Float | 12.34% |
| Short Ratio (days to cover) | 5.18 |
Income Statement
In the last 12 months, IONS had revenue of $874.09 million and -$565.17 million in losses. Loss per share was -$3.46.
| Revenue | 874.09M |
| Gross Profit | -60.60M |
| Operating Income | -594.35M |
| Pretax Income | -562.00M |
| Net Income | -565.17M |
| EBITDA | -75.37M |
| EBIT | -102.29M |
| Loss Per Share | -$3.46 |
Balance Sheet
The company has $2.10 billion in cash and $2.19 billion in debt, with a net cash position of -$86.67 million or -$0.52 per share.
| Cash & Cash Equivalents | 2.10B |
| Total Debt | 2.19B |
| Net Cash | -86.67M |
| Net Cash Per Share | -$0.52 |
| Equity (Book Value) | 439.74M |
| Book Value Per Share | 2.65 |
| Working Capital | 2.18B |
Cash Flow
In the last 12 months, operating cash flow was -$496.43 million and capital expenditures -$64.41 million, giving a free cash flow of -$560.84 million.
| Operating Cash Flow | -496.43M |
| Capital Expenditures | -64.41M |
| Depreciation & Amortization | 14.87M |
| Net Borrowing | 69.67M |
| Free Cash Flow | -560.84M |
| FCF Per Share | -$3.37 |
Margins
Gross margin is -6.93%, with operating and profit margins of -68.00% and -64.66%.
| Gross Margin | -6.93% |
| Operating Margin | -68.00% |
| Pretax Margin | -64.30% |
| Profit Margin | -64.66% |
| EBITDA Margin | -8.62% |
| EBIT Margin | -11.70% |
| FCF Margin | n/a |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.49% |
| Shareholder Yield | -4.49% |
| Earnings Yield | -6.14% |
| FCF Yield | -6.09% |
Analyst Forecast
The average price target for IONS is $89.33, which is 57.74% higher than the current price. The consensus rating is "Buy".
| Price Target | $89.33 |
| Price Target Difference | 57.74% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 28.35% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IONS has an Altman Z-Score of 1.83 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.83 |
| Piotroski F-Score | 2 |